Global Rabies Treatment Market 2020-2024
Technavio has been monitoring the rabies treatment market and it is poised to grow by $ 1.06 bn during 2020-2024, progressing at a CAGR of 5% during the forecast period. Our report on rabies treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the need for contamination-free vaccines with novel culture media, the growing issue of stray animals in developing economies and novel routes of administration. In addition, the need for contamination-free vaccines with novel culture media is anticipated to boost the growth of the market as well.
The rabies treatment market analysis includes product segment, application segment, route of administration segment and geographical landscapes.
Technavio's rabies treatment market is segmented as below:
By Product
By Application
- Pre-exposure vaccination
- Post-exposure prophylaxis
By Route of Administration
- Intradermal route of administration
- Intramuscular route of administration
- Oral route of administration
By Geographical Landscapes
- Asia
- Europe
- North America
- ROW
This study identifies the growing awareness about animal health and welfare as one of the prime reasons driving the rabies treatment market growth during the next few years. Also, the zero human rabies by 2030 initiative and the introduction of monoclonal antibodies will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the rabies treatment market covers the following areas:
- Rabies treatment market sizing
- Rabies treatment market forecast
- Rabies treatment market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading rabies treatment market vendors that include Bavarian Nordic AS, Bharat Biotech Ltd., Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., Grifols SA, Kedrion Spa, Merck & Co. Inc., Sanofi, Serum Institute of India Pvt. Ltd., and Zoetis Inc. Also, the rabies treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.